Jonathan Guarino
Director of Finance/CFO at SOLIGENIX, INC.
Net worth: 313 $ as of 30/04/2024
Jonathan Guarino active positions
| Companies | Position | Start | End |
|---|---|---|---|
| SOLIGENIX, INC. | Director of Finance/CFO | 11/09/2019 | - |
| Corporate Secretary | - | - | |
| Corporate Officer/Principal | 11/09/2019 | - |
Career history of Jonathan Guarino
Former positions of Jonathan Guarino
| Companies | Position | Start | End |
|---|---|---|---|
| HEPION PHARMACEUTICALS, INC. | Comptroller/Controller/Auditor | 01/09/2016 | 01/07/2019 |
| Suite-K Value Added Services LLC | Comptroller/Controller/Auditor | 01/08/2015 | 01/09/2016 |
| COVANCE INC. | Comptroller/Controller/Auditor | 01/06/2014 | 01/05/2015 |
Training of Jonathan Guarino
| Montclair State University | Undergraduate Degree |
Statistics
International
| United States | 6 |
Operational
| Comptroller/Controller/Auditor | 3 |
| Director of Finance/CFO | 1 |
| Corporate Officer/Principal | 1 |
Sectoral
| Health Technology | 4 |
| Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 2 |
|---|---|
| SOLIGENIX, INC. | Health Technology |
| HEPION PHARMACEUTICALS, INC. | Health Technology |
| Private companies | 2 |
|---|---|
Labcorp Drug Development, Inc.
 Labcorp Drug Development, Inc. Pharmaceuticals: MajorHealth Technology Covance, Inc. operates as a contract research organization and drug development company. Its services include research, lead optimization, analysis services, safety assessment and drug safety testing, consulting and partnering, clinical development, informatics, clinical testing, commercialization, and manufacturing support. The company was founded on November 12, 1996 and is headquartered in Princeton, NJ. | Health Technology |
| Suite-K Value Added Services LLC |
- Stock Market
- Insiders
- Jonathan Guarino
- Experience
